World’s largest battery maker announces major breakthrough in energy density
“The launch of condensed batteries will usher in an era of universal electrification of sea, land and air transportation…,” according to Chinese battery manufacturer CATL.
Technology & innovation
This archive covers technology and innovation breakthroughs that improve lives, protect the environment, and expand human possibility. From medical devices to clean energy tools, the stories here focus on what’s working and who’s making it happen.
Alzheimer’s proteins beaten back by sleeping pill in small study
The pills showed promise in combating the substances that lead to the harmful tangles and plaques in the brain that contribute to the disease.
Ghana first country to approve ‘world-changer’ malaria vaccine
Ghana’s approval of the R21 malaria vaccine — the first anywhere in the world — clears the way for children as young as five months to be protected against a disease that kills roughly 620,000 people every year, mostly young kids in Africa. Developed at Oxford’s Jenner Institute, R21 showed up to 80% effectiveness in early trials and is expected to cost just a couple of dollars per dose. The Serum Institute of India is preparing to produce up to 200 million doses a year, with a factory rising in Accra so supply stays close to home. After a century of scientific near-misses, an African regulator stepped forward and said: this one is ready.
New nuclear medicine therapy cures human non-hodgkin lymphoma in preclinical model
A single dose of this radioimmunotherapy was found to eliminate tumor cells and extend the life of mice injected with cancerous cells for more than 221 days (the trial endpoint), compared to just 19 days in untreated control mice.
Switzerland to install solar panels between railway tracks in world first
With the Swiss national railway network stretching beyond 2,000 miles of track, estimates place the amount of power generation at potentially beyond 1 terawatt hour or 2% of the entire gross annual consumption.
Breakthrough drug works against all the main types of primary bone cancer
Bone cancer research has taken a meaningful step forward, with scientists identifying a single drug candidate that shows activity across all the major types of primary bone cancer — a group of diseases that have long resisted a unified treatment approach. Because these cancers disproportionately affect children and young people, the stakes are especially high. The compound appears to target something the different subtypes share biologically, which could open new research directions well beyond this one discovery. For pediatric cancer medicine, that kind of insight builds the foundation treatments are eventually made from.\n\nWord count: 88
Researchers cure toddler of deadly metachromatic leukodystrophy (MLD) for first time in history
Gene therapy has cured 19-month-old Teddi Shaw of metachromatic leukodystrophy, making her the first NHS patient treated for this rare, fatal nervous system disease. After a single infusion of Libmeldy at Royal Manchester Children’s Hospital, she’s now running around, chattering away, and showing no signs of the illness that typically kills children before age eight. The treatment works by correcting a faulty gene in the child’s own stem cells, eliminating the disease at its root rather than managing it. Her family’s joy is tempered by grief — Teddi’s older sister was diagnosed too late for the therapy to help, fueling calls for newborn screening. It’s a glimpse of medicine’s next era: one-time cures for inherited conditions, if access and early detection can keep pace.
GE installs world’s first spiral-welded wind turbine tower
Spiral-welded wind turbine towers could quietly dissolve one of the biggest barriers holding back wind energy: the highway. Because conventional towers must be trucked in, U.S. road regulations cap their diameter — and therefore their height — well below what the physics of wind actually allows. Keystone’s mobile factories build towers on-site from coiled steel, removing that constraint entirely and making towers tall enough to reach stronger, more consistent winds. One tower doesn’t rewrite the industry, but it proves the concept works. If the approach scales, it could bring competitive wind energy to regions that have never had it.
Researchers can now pull green hydrogen directly from seawater
University of Adelaide researchers claim to have made clean hydrogen fuel from seawater without pre-treatment. Their findings could eventually provide cheaper green energy production from a near-limitless source to coastal areas.
First vaccine to target deadly fungal infections passes preclinical tests
Fungal infections kill an estimated 1.6 million people every year, yet until now no vaccine has ever existed for any of the major culprits. Researchers at the University of Georgia have developed a single shot that trains the immune system to recognize all three deadliest fungal genera simultaneously — a feat never before demonstrated in peer-reviewed research. Crucially, it reduced illness and death in immunocompromised animals, the very people most at risk. For a disease category the WHO only recently recognized as a global emergency, this candidate offers the first real hope of prevention.\n\n*(Word count: 88)*